Patents by Inventor Andrew D. Cherniack

Andrew D. Cherniack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RIP140 regulation of glucose transport
    Patent number: 8519118
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: August 27, 2013
    Assignee: University of Massachusetts
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • RIP140 REGULATION OF GLUCOSE TRANSPORT
    Publication number: 20120208862
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Application
    Filed: January 6, 2012
    Publication date: August 16, 2012
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • RIP140 regulation of diabetes
    Patent number: 8093223
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: January 10, 2012
    Assignee: University of Massachusetts
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • RIP140 Regulation of Diabetes
    Publication number: 20100098638
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Application
    Filed: October 8, 2009
    Publication date: April 22, 2010
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • RIP140 regulation of glucose transport
    Patent number: 7691823
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: April 6, 2010
    Assignee: University of Massachusetts
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • Glucose transport-related genes and uses thereof
    Publication number: 20020155472
    Abstract: Nucleotide sequences and amino acid sequences from nucleic acids and proteins involved in glucose transport are disclosed. The sequences are useful for producing DNA arrays that can be used for the diagnosis of, predictive testing for, and development of treatments for disorders involving glucose transport such as type II diabetes.
    Type: Application
    Filed: October 22, 2001
    Publication date: October 24, 2002
    Inventors: Michael P. Czech, Andrew D. Cherniack, Adilson L. Guilherme